XML 72 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions (Details)
 1 Months Ended 12 Months Ended
Jun. 22, 2022
Nov. 15, 2021
USD ($)
shares
Jan. 28, 2021
Dec. 31, 2020
USD ($)
$ / shares
shares
May 31, 2020
Jul. 31, 2022
USD ($)
ft²
Jul. 31, 2021
USD ($)
shares
Related Party Transactions (Details) [Line Items]              
Related party expenses           $ 343,000 $ 322,000
Due to related parties           $ 69,000 136,000
Area of land (in Square Feet) | ft²           80,000  
Rent and parking expenses           $ 2,100,000 2,000,000
Due from related parties           482,000
Related party receivables           $ 720,000  
Description of pharma holdings     On January 28, 2021, Pharma Holdings partially exercised the Warrant and purchased 7.3 million shares of Cornerstone Pharmaceuticals’ Series D Preferred Stock for $9.1 million, of which $0.9 million was contributed by the holder of a minority interest in Pharma Holdings.         
Related party transaction, description           The Company leases space to related parties (including IDT Corporation - see above) which represented approximately 58% and 65% for the years ended July 31, 2022 and 2021, respectively, which includes discontinued operations related party rental income pertaining to the 520 Property. The portion of related party rental income pertaining to the 520 Property has been classified in discontinued operations on the consolidated statements of operations and comprehensive loss for the years ended July 31, 2022 and 2021. See Note 18 for future minimum rent payments from related parties and other tenants.   
Acquired an additional membership interest       33.333% 33.333%    
Aggregate of a membership interest       66.666%      
Recognized loss of earnings           $ 575,000 $ 383,000
Common stock for consideration           $ (6,228,000)  
Warrants percentage       20.00%      
Exercise price (in Dollars per share) | $ / shares       $ 22.91      
Stock purchase agreement description On June 22, 2022, the Company entered into a Stock Purchase Agreement (the “I9 SPA”) with I9 Plus, LLC. On July 6, 2022, pursuant to the I9 SPA, the Company sold 3,225,806 shares of the Company’s Class B common stock to I9 Plus, LLC at a price per share of $1.86 and an aggregate sale price of $6 million.             
Israel [Member]              
Related Party Transactions (Details) [Line Items]              
Area of land (in Square Feet) | ft²           3,600  
RP Finance [Member]              
Related Party Transactions (Details) [Line Items]              
Ownership percentage   84.00%       37.50%  
Class B Common Stock [Member]              
Related Party Transactions (Details) [Line Items]              
Exercised warrants purchased shares (in Shares) | shares             43,649
Securities Purchase Agreement [Member]              
Related Party Transactions (Details) [Line Items]              
Shares purchased (in Shares) | shares       218,245      
Common stock for consideration       $ 5,000,000      
IDT Owed [Member]              
Related Party Transactions (Details) [Line Items]              
Rent and parking expenses           $ 157,000 $ 168,000
Rafael Pharmaceuticals [Member]              
Related Party Transactions (Details) [Line Items]              
Due from related parties           120,000 480,000
Due from owed amount           720,000 600,000
LipoMedix Pharmaceuticals, Ltd. [Member]              
Related Party Transactions (Details) [Line Items]              
Due from owed amount   $ 3,000,000          
Outstanding loan balance   400,000          
Accrued interest   21,800          
Cash payment   $ 2,600,000          
Purchased shares (in Shares) | shares   15,975,000          
Noncontrolling interest percentage   16.00%          
IDT [Member]              
Related Party Transactions (Details) [Line Items]              
Rent and parking expenses           $ 1,800,000 $ 1,700,000